Reading Room Production — page 153

ol CL 4PM [AID DEA DART NIAID) [E] i I NIAID) [E] VIH/NIAID) [E] ii NIH/NIAID) [E] J VIH/NIAID) [I] iy >; I I (NIH/NIAID) [E] NIH/NIAID) [E] ay NIAID) [E] ndences ay > ents on the bill HHS is asking In particular, we have flagged a OLPA plans to include the specific sked to review consolidated NIH Please let me know if you have any questions. Thanks, Sara Re-submitted NIAID comments in the attached document (highlighted in yellow): p. 1: New NIH comment p. 2: NIH addition to OASH/OHRP comment p. 3: New NIH comment p. 4: NIH addition to OASH/OHRP comment p. 9: NIH edit to OGC comment to broaden scope to all agencies (previously flagged by OCGR-Leg) p. 10: NIH addition (from NIAID) to existing NIH comment p. 12: NIH addition to OIG comment p. 14: NIH addition to OGC comment p. 16: NIH addition (from NIAID) to existing NIH comment From: Selgrade, Sara (NIH/NIAID) [E] @nih.gov> Sent: Tuesday, July 16, 2024 12:24 PM To: NIAID BUGS @niaid.nih.gov>; NIAID DEA DART @mail.nih.gov>; NIAID DIR-OCGR <NIAIDDIR- @mail.nih.gov>; Nealy, Michael (NIH/NIAID) [E] @nih.gov>; Auchincloss, Hugh (NIH/NIAID) [E] @niaid.nih.gov>; Harper, Jill (NIH/NIAID) [E] @niaid.nih.gov>; Parker, Marie (NIH/NIAID) [E] @niaid.nih.gov>; Billet, Courtney (NIH/NIAID) [E] @niaid.nih.gov> Cc: NIAID OCGR Leg @mail.nih.gov>; Erbelding, Emily (NIH/NIAID) [E] @nih.gov>; Holland, Steven (NIH/NIAID) [E] @niaid.nih.gov>; Hanson, Christopher (NIH/NIAID) [E] @niaid.nih.gov>; Poe, Kelly (NIH/NIAID) [E] @nih.gov>; Gilles, Sharon (NIH/NIAID) [E] @nih.gov>; DDSM Correspondences @mail.nih.gov> Subject: Please review by COB today Tues 7/16: HHS Comments to OMB on Risky Research Review Act Importance: High Hello all, Background Thank you again for your assistance in reviewing the Risky Research Review Act. HHS has compiled comments on the bill from throughout HHS to provide them to the Office of Management and Budget (OMB) for consideration. HHS is asking NIH to review the attached document on quick turnaround. The comments included in the document provide high-level concerns across HHS. In particular, we have flagged a comment on the bottom of page 9 with a proposed clarifying edit for your review. Action Item Please review the attached draft HHS comments on the Risky Research Review Act and provide your concurrence, or any edits, by COB today, Tuesday July 16th. If you have any concerns with OCGR-Leg's proposed edit to the comment on page 9, please let us know. Please note that NIH OLPA is also working on a separate request from the Senate Health, Education, Labor, and Pensions (HELP) Committee (Chair: Sen. Bernie Sanders, I-VT) for technical assistance on this bill. OLPA plans to include the specific NIAID comments shared yesterday in this separate request. We anticipate we may be asked to review consolidated NIH comments for the HELP Committee this week. Thank you for your ongoing assistance with reviewing this bill. Please let me know if you have any questions.